Ads
related to: amgen kyprolis- About Kyprolis®
Learn More About Combination
Therapy Options For Your Patients.
- Safety Information
Find Important Safety Information
For Kyprolis®. Learn More Today.
- Amgen SupportPlus
Find Support, Tools, And Resources
For HCPs, Caregivers And Patients.
- HCP FAQs
Discover Answers To Commonly Asked
Questions At The Official HCP Site.
- Connect With A Rep
Contact A Field Representative For
Questions Or To Schedule A Visit.
- Efficacy Information
Review Clinical Data, Results,
Study Overviews, And More.
- About Kyprolis®
Search results
Amgen (AMGN) Beats on Q3 Earnings Beat, Lags Sales, Ups View
Zacks via Yahoo Finance· 8 months agoAmgen (AMGN) beats Q3 estimates for earnings but misses on sales. Following the acquisition of...
Amgen (AMGN) Q1 Earnings Beat Estimates, 2023 View Raised
Zacks via Yahoo Finance· 1 year agoAmgen AMGN reported first-quarter 2023 earnings of $3.98 per share, which beat the Zacks Consensus...
Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
Zacks via Yahoo Finance· 2 months agoAmgen (AMGN) beats first-quarter 2024 estimates for earnings and sales. Amgen is "very encouraged"...
Can Amgen (AMGN) Keep the Earnings Streak Alive in Q1?
Zacks via Yahoo Finance· 1 year agoVolume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others is...
Amgen (AMGN) Beats Q2 Earnings Estimates, to Buy Chemocentryx
Zacks via Yahoo Finance· 2 years agoAmgen AMGN reported second-quarter 2022 earnings of $4.65 per share, which beat the Zacks Consensus...
Amgen (AMGN) Valuation: A Comprehensive Analysis of Its Market Value
GuruFocus.com via Yahoo Finance· 9 months agoAs of October 10, 2023, Amgen Inc (NASDAQ:AMGN) experienced a day's loss of -1.02%, with a 3-month...
Amgen (AMGN) Outperforms Industry Year to Date: What's Next?
Zacks via Yahoo Finance· 2 years agoAmgen's (AMGN) key drugs like Prolia, Repatha and Xgeva are driving sales. Amgen is also rapidly...
The Amgen Inc (AMGN) Company: A Short SWOT Analysis
GuruFocus.com via Yahoo Finance· 8 months agoAmgen Inc (NASDAQ:AMGN) continues to lead in biotechnology-based human therapeutics, with a strong portfolio of flagship drugs. The company's recent...
Why Is Amgen (AMGN) Down 4.2% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 year agoIt has been about a month since the last earnings report for Amgen (AMGN). Shares have lost about...
Amgen Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 7 months agoAmgen Inc(NASDAQ:AMGN) recently announced a dividend of $2.13 per share, payable on 2023-12-08, with the ex-dividend date set for 2023-11-16. As...
Ads
related to: amgen kyprolis
